
ABOUT CENCORA PHARMALEX
Beginning in January 2024, companies in the PharmaLex family started a journey of rebranding aligned with Cencora, our parent company and a leading global pharmaceutical solutions organization centered on improving lives around the world.
PharmaLex adds to Cencora’s expanding suite of pharma solutions and serves the pharma, biotech, and medtech industries. We guide clients from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-elevated solutions to support clients through the entire product lifecycle.
View our content to discover how our expanded capabilities can help you – or contact a Cencora PharmaLex expert today with any questions.
CONTACT INFORMATION
Cencora PharmaLex
1 W 1st Ave.
Conshohocken, PA 19428
UNITED STATES
FEATURED INSIGHTS
-
The oncology landscape is brimming with innovative therapies and new treatment approaches. Successful commercialization requires a well-orchestrated strategy to bring these complex products to market.
-
The healthcare industries in the U.S. and EU are undergoing significant regulatory and legislative changes. Learn how to better position yourself to navigate this complex environment.
-
A new regulation in the EU will give patients more control over their health data. Discover the opportunities and challenges this shift presents for the future of patient-centric healthcare.
-
AI and digital innovation are reshaping the pharmaceutical landscape. Learn how the industry is leveraging data and technology to enhance commercialization and improve patient outcomes.
-
The biosimilar market is projected to reach over $100 billion in the next five years. Learn how to navigate the expanding landscape and overcome challenges in accessing key clinical information.
-
Navigating pre-approval information exchange (PIE) with healthcare decision-makers is essential for market success. Learn what information can be shared and the best strategies for communication.
GET MORE DETAILS ON OUR SOLUTIONS
-
PhlexTMF offers the industry’s only next-generation eTMF AI, providing expert suggestions at the critical document upload step, reducing errors, and improving TMF quality, completeness, and timeliness.
-
Discover how intelligent, automated clinical trial safety reporting software can enhance compliance, reduce costs, and boost site responsiveness rates effortlessly.
-
Enable busy study teams to assess, prevent, and manage risk across the entire TMF spectrum – improving inspection-readiness with less effort.
-
Learn about a fast, efficient, and cost-effective solution for deploying Oracle Argus that ensures minimal downtime, reduced validation effort, and increased ROI.
-
Explore the top 3 insights on the impact of pre-approval communication and learn why healthcare decision makers want more pre-approval resources and engagement from manufacturers.
-
As deadlines loom for transitioning ongoing clinical trials in the EU to the Clinical Trials Regulation (CTR), understanding key timelines and dates becomes critical.
EXPLORE OUR THOUGHT LEADERSHIP
Explore the latest insights from the Cencora team.
WHITE PAPERS
-
Project Orbis Drug Registration 2025
Project Orbis helps streamline the review and approval of oncology medicinal products through international regulatory collaboration. Learn how this framework can accelerate your regulatory strategy.
-
Unlock Oncology Success With A Comprehensive Commercialization Guide
Navigate the complex process of bringing an oncology therapy to market, from regulatory planning to patient access and supply chain logistics, with this comprehensive handbook for developers.
-
Digital Innovation In Pharmacovigilance
Explore how AI can transform your pharmacovigilance efforts and enhance patient safety by leveraging the insights and decision framework outlined here.
VIDEOS AND WEBINARS
-
Navigating The Regulatory Complexities Of Targeted Medicines In Oncology
Explore the strategic considerations for successfully navigating the regulatory complexities of targeted medicines. Learn about the challenges in translational medicine and key clinical development considerations.
-
Connecting Manufacturers And Providers To The Services Needed For Full End-To-End Patient And Order Management
Streamline complex cell and gene therapy logistics with an integrated platform that connects manufacturers with vital services, providing full visibility and control for a more efficient and successful patient journey.
-
Crafting Scalable Solutions For Maximum Reach And Success
Is your supply chain ready for a blockbuster cell and gene therapy launch? Industry leaders discuss selecting partners, managing risk, and scaling operations for maximum reach and success.
-
Maximizing Impact: Strategies For Building Robust Patient Support Programs
Panelists explore the entire patient journey, from diagnosis to treatment, sharing strategies for creating practical, seamless support systems that ensure access to innovative cell and gene therapies.
-
Navigating Special Regulatory Pathways For Advanced Therapy Development Success
Don't let regulatory hurdles slow you down. Learn from leading experts about special designations like RMAT and PRIME to accelerate your advanced therapy development and ensure success.
PODCASTS
-
Navigating The Digital Era And Beyond For Engaging Key Decision Makers In Specialty Pharmacy
Tune in as experts discuss how biopharma companies can effectively engage healthcare decision-makers in the evolving digital landscape.
-
Exploring The Interactions Between Validation, Technology Transfer
Listen as Gerardo Gomez delves into the intricate relationship between validation and technology transfer, taking into account the perspectives and standards set by regulators.
-
Early Access Programs: What They Are And How To Plan For Them
Explore how early access programs are tailored to individual sufferers of rare, ultra-rare, or life-threatening conditions, as well as cohort programs, which target groups of patients afflicted with the same disease.
-
Navigating The Process Of Technology Transfer
Olena Chervonenko, Associate Director Quality Management and Compliance at PharmaLex, provides deeper insights into technology transfer and essential factors for achieving success.
-
Scaling Patient Safety Through Innovation
In this podcast episode, Michael Braun-Boghos and Cheryl James share their expertise and perspectives on leveraging innovative approaches to enhance patient safety initiatives.
E-BOOKS AND OTHER INSIGHTS
-
How Patient-Centric Approaches Are Shaping The Future Of CGT
Emily Whitehead’s CAR-T cell therapy journey highlights the power of patient engagement in cell and gene therapies. Discover how her story and advocacy drive a patient-centric approach in innovative treatments.
-
A Comparative Guide To CGTs: Modalities, Landscape, And Logistics
Cell and gene therapies (CGTs) have the potential to revolutionize medicine. However, achieving therapeutic success requires advanced logistical consideration to ensure product safety and efficacy
-
Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And Solutions
Explore critical logistical requirements in autologous cell therapies logistics and learn how to overcome challenges and achieve successful and timely autologous cell therapy trials.